Rare disease diagnostics involves the identification and diagnosis of medical conditions that are considered rare or uncommon. These diagnostics play a crucial role in early detection and diagnosis, aiding in the selection of targeted and personalized treatment plans for uncommon disorders.
The primary tests included in rare disease diagnostics are genetic tests, general lab tests, and imaging tests. Genetic tests are laboratory procedures that examine chromosomes, genes, or gene expression in human cells or tissue. Various technologies, including capillary sequencing, whole genome sequencing, whole exome sequencing, and microarrays, utilize different samples such as DNA samples, buccal swab samples, blood, and saliva for the diagnosis of various diseases. These diseases include gastroenterology diseases, endocrine and metabolism disorders, hematology and oncology diseases, dermatology diseases, cardiovascular disorders, and neurology diseases. Rare disease diagnostics are employed by various end-users, including hospital laboratories, diagnostics laboratories, genetic testing laboratories, and cancer research laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The rare disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides rare disease diagnostics market statistics, including rare disease diagnostics industry global market size, regional shares, competitors with a rare disease diagnostics market share, detailed rare disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rare disease diagnostics industry. This rare disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rare disease diagnostics market size has grown strongly in recent years. It will grow from $35.23 billion in 2024 to $38.14 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the rise in demand for cloud-based diagnostics, increased focus on improving efficiency, increased prevalence of neurological disease, increased immunological disorders, increased healthcare spending.
The rare disease diagnostics market size is expected to see rapid growth in the next few years. It will grow to $56.08 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing prevalence of rare diseases, increasing government initiatives, increasing number of hospitals and diagnostic laboratories, growing hematology diseases, increasing healthcare infrastructure. Major trends in the forecast period include advancements in genetic testing technologies, introduction of whole-genome sequencing and next-generation sequencing (NGS), extensive investments, strategic collaborations for research initiatives.
The forecast of 10.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. providers by driving up the cost of next-generation sequencing panels and CRISPR-based detection kits sourced from the UK and South Korea, exacerbating diagnostic delays and raising genetic testing expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rare disease diagnostics market is poised for growth, driven by the increasing incidence of rare diseases. Rare diseases, characterized by their low prevalence in the population, necessitate specialized diagnostics for effective management, identification of potential therapeutics, and avoidance of unnecessary treatments. For instance, data from the International Osteoporosis Foundation (IOF) in February 2021 highlighted that over 300 million people worldwide suffer from rare diseases, affecting 3.5% to 5.9% of the global population. Additionally, Health Match reported in November 2022 that there are approximately 150 rare kidney ailments with a prevalence of 60-80 incidences per 100,000 people in America and Europe. Hence, the rising incidence of rare diseases is a driving force for the growth of the rare disease diagnostics market.
The growing aging population is another factor propelling the expansion of the rare disease diagnostics market. With an aging population, there is an increased need for early identification and personalized treatment approaches facilitated by rare disease diagnostics. According to The United States Census Bureau's June 2023 report, the median age in the United States rose to 38.9 years in 2022, indicating a continuous aging trend in the population. This demographic shift is contributing to the growth of the rare disease diagnostics market by improving the overall management of health conditions in the elderly.
Advancements in technology have become a prominent trend in the rare disease diagnostics market, with major companies adopting new technologies to sustain their market position. For example, in April 2023, Centogene GmbH introduced CentoGenome, a whole genome sequencing solution designed for diagnosing rare and neurodegenerative diseases. This advanced next-generation sequencing (NGS)-based assay covers a wide range of disease-causing variants, offering a comprehensive approach to rare disease diagnostics.
Major companies in the rare disease diagnostics market are also focusing on developing innovative products, such as genetic testing, to enhance their market share. Genetic testing for rare cancers involves using advanced genetic analysis techniques to identify and understand genetic components associated with these diseases. Illumina, a biotechnology company, launched the TruSight Oncology Comprehensive test kit in March 2022, which analyzes 517 cancer-related genes across nearly 30 solid tumor types in a single tissue sample.
In April 2022, Sema4 Holding Corp., a patient-centered health intelligence company, acquired GeneDx for $623 million. This strategic acquisition is expected to bolster Sema4's AI-driven genomic and clinical data analytics platform. GeneDx is a genomic testing service provider specializing in the diagnosis of rare and ultra-rare pediatric genetic illnesses.
Major companies operating in the rare disease diagnostics market include Thermo Fisher Scientific Inc., Roche Diagnostics, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Astellas Pharma Inc., Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Sanofi Genzyme, Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BioMarin Pharmaceutical Inc., OPKO Health Inc., Sarepta Therapeutics Inc., Natera Inc., Invitae Corporation, Ultragenyx Pharmaceutical Inc., Travere Therapeutics Inc., BGI Genomics Co. Ltd., 23andMe Holding Co., Ambry Genetics Corporation, Centogene N.V., GENEWIZ Inc., Blueprint Genetics Inc., Oxford Gene Technology Limited, Strand Life Sciences Pvt. Ltd., Agios Pharmaceuticals Inc., Orphazyme A/S, RareCyte Inc.
North America was the largest region in the rare disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the rare disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The rare disease diagnostics market consists of revenues earned by entities by providing services such as clinical evaluation, parallel sequencing, targeted sequencing, laboratory testing, and specialist consultation. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare disease diagnostics market also includes sales of vision evaluation instruments, blood pressure cuffs, cardiac monitors, and advanced imaging equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Rare Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rare disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rare disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Test Type: Genetic Test; General Lab Test; Imaging Test
- 2) By Technology: Capillary Sequencing; Whole Genome Sequencing; Whole Exome Sequencing; Microarrays
- 3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample; Buccal Swab Sample; Blood; Saliva
- 4) By Disease Type: Gastroenterology Disease; Endocrine And Metabolism Disorders Disease; Hematology And Oncology Disease; Dermatology Disease; Cardiovascular Disorders; Neurology Disease
- 5) By End User: Hospital Laboratories; Diagnostics Laboratories; Genetic Testing Laboratories; Cancer Research Laboratories
- Subsegments:
- 1) By Genetic Test: Whole Genome Sequencing; Targeted Gene Panels; Exome Sequencing; Carrier Testing
- 2) By General Lab Test: Blood Tests; Biochemical Assays; Urine Tests; Cytogenetic Tests
- 3) By Imaging Test: MRI (Magnetic Resonance Imaging); CT (Computed Tomography) Scans; Ultrasound; X-Rays
- Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Astellas Pharma Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; PerkinElmer Inc.; Sanofi Genzyme; Illumina Inc.; Bio-Rad Laboratories Inc.; Qiagen NV; BioMarin Pharmaceutical Inc.; OPKO Health Inc.; Sarepta Therapeutics Inc.; Natera Inc.; Invitae Corporation; Ultragenyx Pharmaceutical Inc.; Travere Therapeutics Inc.; BGI Genomics Co. Ltd.; 23andMe Holding Co.; Ambry Genetics Corporation; Centogene N.V.; GENEWIZ Inc.; Blueprint Genetics Inc.; Oxford Gene Technology Limited; Strand Life Sciences Pvt. Ltd.; Agios Pharmaceuticals Inc.; Orphazyme A/S; RareCyte Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Rare Disease Diagnostics Market Characteristics
3. Rare Disease Diagnostics Market Trends And Strategies
4. Rare Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Rare Disease Diagnostics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Rare Disease Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Rare Disease Diagnostics Market Growth Rate Analysis
- 5.4. Global Rare Disease Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Rare Disease Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Rare Disease Diagnostics Total Addressable Market (TAM)
6. Rare Disease Diagnostics Market Segmentation
- 6.1. Global Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Test
- General Lab Test
- Imaging Test
- 6.2. Global Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Capillary Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Microarrays
- 6.3. Global Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Deoxyribonucleic Acid (DNA) Sample
- Buccal Swab Sample
- Blood
- Saliva
- 6.4. Global Rare Disease Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gastroenterology Disease
- Endocrine And Metabolism Disorders Disease
- Hematology And Oncology Disease
- Dermatology Disease
- Cardiovascular Disorders
- Neurology Disease
- 6.5. Global Rare Disease Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Laboratories
- Diagnostics Laboratories
- Genetic Testing Laboratories
- Cancer Research Laboratories
- 6.6. Global Rare Disease Diagnostics Market, Sub-Segmentation Of Genetic Test, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Whole Genome Sequencing
- Targeted Gene Panels
- Exome Sequencing
- Carrier Testing
- 6.7. Global Rare Disease Diagnostics Market, Sub-Segmentation Of General Lab Test, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Blood Tests
- Biochemical Assays
- Urine Tests
- Cytogenetic Tests
- 6.8. Global Rare Disease Diagnostics Market, Sub-Segmentation Of Imaging Test, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- MRI (Magnetic Resonance Imaging)
- CT (Computed Tomography) Scans
- Ultrasound
- X-Rays
7. Rare Disease Diagnostics Market Regional And Country Analysis
- 7.1. Global Rare Disease Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Rare Disease Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Rare Disease Diagnostics Market
- 8.1. Asia-Pacific Rare Disease Diagnostics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Rare Disease Diagnostics Market
- 9.1. China Rare Disease Diagnostics Market Overview
- 9.2. China Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Rare Disease Diagnostics Market
- 10.1. India Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Rare Disease Diagnostics Market
- 11.1. Japan Rare Disease Diagnostics Market Overview
- 11.2. Japan Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Rare Disease Diagnostics Market
- 12.1. Australia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Rare Disease Diagnostics Market
- 13.1. Indonesia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Rare Disease Diagnostics Market
- 14.1. South Korea Rare Disease Diagnostics Market Overview
- 14.2. South Korea Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Rare Disease Diagnostics Market
- 15.1. Western Europe Rare Disease Diagnostics Market Overview
- 15.2. Western Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Rare Disease Diagnostics Market
- 16.1. UK Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Rare Disease Diagnostics Market
- 17.1. Germany Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Rare Disease Diagnostics Market
- 18.1. France Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Rare Disease Diagnostics Market
- 19.1. Italy Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Rare Disease Diagnostics Market
- 20.1. Spain Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Rare Disease Diagnostics Market
- 21.1. Eastern Europe Rare Disease Diagnostics Market Overview
- 21.2. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Rare Disease Diagnostics Market
- 22.1. Russia Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Rare Disease Diagnostics Market
- 23.1. North America Rare Disease Diagnostics Market Overview
- 23.2. North America Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Rare Disease Diagnostics Market
- 24.1. USA Rare Disease Diagnostics Market Overview
- 24.2. USA Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Rare Disease Diagnostics Market
- 25.1. Canada Rare Disease Diagnostics Market Overview
- 25.2. Canada Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Rare Disease Diagnostics Market
- 26.1. South America Rare Disease Diagnostics Market Overview
- 26.2. South America Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Rare Disease Diagnostics Market
- 27.1. Brazil Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Rare Disease Diagnostics Market
- 28.1. Middle East Rare Disease Diagnostics Market Overview
- 28.2. Middle East Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Rare Disease Diagnostics Market
- 29.1. Africa Rare Disease Diagnostics Market Overview
- 29.2. Africa Rare Disease Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Rare Disease Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Rare Disease Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Rare Disease Diagnostics Market Competitive Landscape And Company Profiles
- 30.1. Rare Disease Diagnostics Market Competitive Landscape
- 30.2. Rare Disease Diagnostics Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Rare Disease Diagnostics Market Other Major And Innovative Companies
- 31.1. Eurofins Scientific SE
- 31.2. Agilent Technologies Inc.
- 31.3. PerkinElmer Inc.
- 31.4. Sanofi Genzyme
- 31.5. Illumina Inc.
- 31.6. Bio-Rad Laboratories Inc.
- 31.7. Qiagen NV
- 31.8. BioMarin Pharmaceutical Inc.
- 31.9. OPKO Health Inc.
- 31.10. Sarepta Therapeutics Inc.
- 31.11. Natera Inc.
- 31.12. Invitae Corporation
- 31.13. Ultragenyx Pharmaceutical Inc.
- 31.14. Travere Therapeutics Inc.
- 31.15. BGI Genomics Co. Ltd.
32. Global Rare Disease Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Rare Disease Diagnostics Market
34. Recent Developments In The Rare Disease Diagnostics Market
35. Rare Disease Diagnostics Market High Potential Countries, Segments and Strategies
- 35.1 Rare Disease Diagnostics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Rare Disease Diagnostics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Rare Disease Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
